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https://doi.org/10.1016/j.celrep.2020.107613SUMMARYDuring inflammation, recruited monocytes can differentiate either into macrophages or dendritic cells (DCs);
however, little is known about the environmental factors that determine this cell fate decision. Low extracellular
pH is a hallmark of a variety of inflammatory processes and solid tumors. Here, we report that low pH dramat-
ically promotes the differentiation of monocytes into DCs (monocyte-derived DCs [mo-DCs]). This process is
associated with a reduction in glucose consumption and lactate production, the upregulation of mitochondrial
respiratory chain genes, and the inhibition of mTORC1 activity. Interestingly, we also find that both serum star-
vation and pharmacological inhibition of mTORC1markedly promote the differentiation of mo-DCs. Our study
contributes to better understanding themechanisms that govern the differentiation ofmonocytes into DCs and
reveals the role of both extracellular pH and mTORC1 as master regulators of monocyte cell fate.INTRODUCTION
Dendritic cells (DCs) play a critical role in the initiation of the
adaptive immune response and the maintenance of self-toler-
ance (Banchereau and Steinman, 1998; Hawiger et al., 2001).
Three major subsets of DCs have been defined in the steady
state: plasmacytoid DCs (pDCs), type 1 conventional DCs
(cDC1), and type 2 cDCs (Geissmann et al., 2010; Guilliams
et al., 2014; Merad et al., 2013; Mildner and Jung, 2014). Inflam-
matory processes are associated with the development of an
additional DC subset, so-called monocyte-derived DCs (mo-
DCs) (Boltjes and van Wijk, 2014; Cheong et al., 2010; Greter
et al., 2012; Segura and Amigorena, 2013; Shortman and Naik,
2007). mo-DCs have also been described in steady-state condi-
tions (Richter et al., 2018; Tamoutounour et al., 2013; Coillard
and Segura, 2019).
Low pH is a hallmark of a variety of inflammatory processes in
peripheral tissues. Values of extracellular pH as low as 6.0 have
been described in the course of inflammation triggered by bac-
terial infections (Abbot et al., 1990; Bryant et al., 1980; Dubos,
1955; Edlow and Sheldon, 1971; Simmen et al., 1994; Simmen
and Blaser, 1993) and also in the context of autoimmune dis-
eases (Geborek et al., 1989; Månsson et al., 1990). Moreover,
extracellular acidosis (range, 5.8 to 7.4) is a hallmark of solid tu-
mors as well as a major determinant of tumor progression
(Ashby, 1966; Corbet and Feron, 2017; Helmlinger et al., 1997).
Little is known about the factors that determine whether
monocytes will differentiate into macrophages or DCs. Using hu-This is an open access article undman monocytes, we report here that low pH and mTORC1 inhi-
bition markedly promote the differentiation of mo-DCs.
RESULTS
LowpHSkews theDifferentiation ofMonocytes intoDCs
Goudot et al. (2017) have shown that culturing monocytes with
macrophage colony stimulating factor (M-CSF), interleukin-4
(IL-4), and tumor necrosis factor alpha (TNF-a) yields a heteroge-
neous population of cells, including a subpopulation of mo-DCs
(CD1a+CD16 cells). Using this approach, we analyzed the influ-
ence exerted by extracellular pH on the differentiation of
mo-DCs. Figure 1A shows that pH 6.5 markedly promoted the
differentiation of monocytes into DCs (CD1a+CD16 cells).
Quantification of the absolute number of cells in each cell popu-
lation (Figure 1A, right panel) and kinetic studies (Figure S1A)
confirmed that the enrichment in CD1a+CD16 cells at pH 6.5 re-
flected an enhanced differentiation of monocytes into DCs and
not a reduction in the viability of CD1a cells. Even a small reduc-
tion in the pH resulted in an enhanced frequency of mo-DCs. In
fact, a significant increase in DC differentiation was observed at
pH 7.0 compared with pH 7.3 (p < 0.01, n = 5) (Figure 1B). At pH
values lower than 6.0, a progressive decline in cell viability was
observed after 2 days of culture (data not shown), precluding
the analysis of DC differentiation. Interestingly, the culture of
monocytes at pH 6.5 for 24 h followed by an additional period
of 4 days at pH 7.3 significantly promoted the differentiation of
DCs, whereas the culture of monocytes at pH 6.5 for 3 days,Cell Reports 31, 107613, May 5, 2020 ª 2020 The Authors. 1
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OPEN ACCESSfollowed by 2 days at pH 7.3, promoted DC differentiation in a
similar fashion as monocytes cultured for 5 days at pH 6.5 (Fig-
ure S1B). Further studies were performed to determine whether
acidosis might bypass the requirement of M-CSF, IL-4, or TNF-a
for mo-DC differentiation. In the absence of M-CSF, high
apoptosis levels were observed early in the cultures, either at
pH 7.3 or pH 6.5 (data not shown). Acidosis was shown to be
unable to induce the differentiation of mo-DCs in the absence
of IL-4 but significantly promoted their differentiation in the
absence of TNF-a (Figure S1C).
Morphological studies revealed that most of the cells cultured
with M-CSF, IL-4, and TNF-a at pH 6.5 showed a typical DC
morphology, whereas cells cultured at pH 7.3 differentiated
into macrophage-like cells (Figure 1C). Differentiation of mo-
DCs has been shown to be dependent on the activity of the
aryl hydrocarbon receptor (AHR) (Goudot et al., 2017). Using
two AHR inhibitors, stemregenin-1 or 4,7-dimethyl-1,10-phe-
nanthroline (4,7-DM Phe), we found a marked prevention of
mo-DCs differentiation at low pH. In contrast, the natural AHR
agonist 6-formylin-dolo (3,2-b) carbazole (FICZ) significantly
promoted DC differentiation at pH 7.3 (Figure 1D). These results
suggest that AHR plays an important role in the differentiation of
mo-DCs.
Functional studies revealed an increased expression of human
leukocyte antigen (HLA)-DR and CD86 upon lipopolysaccharide
(LPS) stimulation in cultures performed at pH 7.3 or pH 6.5 (Fig-
ure 1E, left panel). Cells cultured at pH 6.5 showed a higher pro-
duction of IL-1b and a lower production of IL-10 upon LPS stim-
ulation (Figure 1E, right panel). Moreover, they showed a high
ability to induce the proliferation of allogeneic T cells (Figures
1F–1H) and the production of IFN-g by alloreactive lymphocytes
(Figure 1I). To better characterize the functional profile of mo-
DCs we also used sorted cells. Sorted CD16 CD1a+ cells
(mo-DCs) obtained at either pH 7.3 or 6.5 produced higher levels
of IL-1b and lower levels of IL-10 upon LPS stimulation than
CD16+ CD1a cells (n = 4, p < 0.01). As expected, sorted
CD16+ CD1a cells displayed a negligible ability to induce the
proliferation and the production of IL-2 and IFN-g by allogeneic
T cells. In contrast, CD16 CD1a+ cells (mo-DCs) obtained at
either pH 7.3 or 6.5 showed a high ability to induce both re-
sponses (Figures 1J and 1K). Consistent with the ability of corti-
costeroids and prostaglandin E2 (PGE2) to promote the develop-Figure 1. Low pH Promotes the Differentiation of mo-DCs in the Conte
(A–C) Isolated monocytes (5 3 105/ml) were cultured for 5 days at different pH
(5 ng/ml), and IL-4 (30 ng/ml). Then, the expression of CD1a and CD16 was det
rescence microscopy (C).
(D) Monocytes were cultured as described in (A), in the absence or presence of
hydroindolo(3,2-b)carbazole-6-carboxaldehyde (FICZ, 65 nM). Then, the express
(E–I) Monocytes were cultured as described in (A). Then, cells were stimulated, or n
panel), the production of cytokines (ELISA) (E, right panel), and cell ability to induce
T lymphocytes (I) were evaluated. A CD4+ T cell/antigen presenting cell ratio of
presenting cells were used. Monocytes were cultured as described in (A). Then, C
and CD16/CD1a+ cells from cultures performed at pH 6.5 were sorted by fluores
24 h, and their ability to induce the proliferation and the production of IFN-g and IL
of 4:1) were evaluated (J and K).
(L) Cells were cultured as described in (A), in the absence or presence of dexameth
evaluated. Representative experiments (n = 3–15) are shown in (A, left), (B), (C), (D
(K), results are expressed as the mean ± SEM of 4–6 different donors. *p < 0.05,ment of tolerogenic DCs (Kalinski et al., 1997; Obermajer et al.,
2011; Woltman et al., 2000), we found that dexamethasone
and PGE2 almost completely prevented the differentiation of
mo-DCs either at pH 7.3 or pH 6.5 (Figure 1L).
Having shown the ability of low pH to promote the differentia-
tion of mo-DCs in the context of M-CSF/IL-4/TNF-a stimulation,
we analyzed whether a similar phenomenon might be observed
in a more complex system. We analyzed the effect induced by
low pH on whole peripheral blood mononuclear cells (PBMCs)
stimulated by phytohemagglutinin (PHA) for 7 days and studied
the phenotype of CD11b+ cells within the monocyte/macro-
phage gate of the forward scatter/side scatter (FSC/SSC) dot
plot. Cultures performed at pH 7.3 yielded two major cell popu-
lations (CD14 and CD14+ cells), both of which were negative for
CD1a expression. In contrast, cultures performed at pH 6.5 re-
sulted in the differentiation of a population of CD1a+ CD14 cells
(Figure S2A) that expressed CD1c, HLA-DR, dendritic cell-spe-
cific intercellular adhesion molecule-3-grabbing non-integrin
(DC-SIGN), and CD11c but not CD16 and CD64 (Figure S2B).
We then analyzed the phenotypic changes induced by LPS stim-
ulation. In these experiments, we used two cell populations as
controls, namely, classical DCs differentiated from monocytes
cultured with IL-4 and granulocyte macrophage colony-stimu-
lating factor (GM-CSF) and macrophages differentiated from
monocytes cultured with M-CSF. DCs differentiated from PHA-
stimulated PBMCs cultured at pH 6.5 and classical DCs showed
a similar maturation response after LPS stimulation, whereas
monocyte-derived macrophages showed only minor phenotypic
changes (Figure S2C). We also analyzed the ability of DCs to
induce the proliferation of allogeneic CD4+ T cells. PHA-stimu-
lated PBMCs were cultured for 7 days at pH 6.5, and
CD1a+CD16 cells were then sorted and activated for 24 h
with LPS. Contrasting with the observations made with mono-
cyte-derived macrophages, sorted CD1a+CD16 cells triggered
a proliferative response similar to that induced by classical DCs
(Figure S2D).
Because serum is able to modulate monocyte function (Gogo-
lak et al., 2007; Leslie et al., 2008), we analyzed if a similar
phenomenon would be observed in cultures performed in
serum-freemedium.Monocytes were cultured for 5 dayswithout
cytokines at pH 6.5 or 7.3 in medium supplemented with 0.1%
BSA. Under these conditions, we could recover only a fractionxt of M-CSF, TNF-a, and IL-4 Stimulation
values, in medium supplemented with 10% FCS, M-CSF (100 ng/ml), TNF-a
ermined by flow cytometry (A–B), and cell morphology was analyzed by fluo-
stemregenin 1 (8 mM), 4,7-dimethyl-1, 10-phenanthroline (50 mM), or 5,11-di-
ion of CD1a, CD14, and CD16 was determined.
ot, with LPS (20 ng/ml) for 24 h, and the expression of HLA-DR andCD86 (E, left
the proliferation (F–H) and the production of IFN-g and IL-5 by allogeneic CD4+
4:1 was used in (F), (H), and (I). In (G), different ratios of CD4+T cells: antigen
D16+/CD1a cells and CD16/CD1a+ cells from cultures performed at pH 7.3
cence-activated cell sorting (FACS). Cells were treated with LPS (20 ng/ml) for
-2 by allogeneic CD4+ T lymphocytes (CD4+ T cell/antigen presenting cell ratio
asone (100 nM) or PGE2 (100 nM). Then, the expression of CD1a andCD14was
, left), (F), and (J, left), and (L). In (A, right), (D, right), (E), (G), (H), (I), (J, right), and
**p < 0.001, and*** p < 0.0001; pH 7.3 versus pH 6.5.




Figure 2. Low Extracellular pH Decreases Intracellular pH and Induces a Starvation-like Response
(A) Monocytes (53 105/ml) were loaded with the fluorescent dye BCECF-AM and cultured for 18 h in medium supplemented with 10% FCS, M-CSF (100 ng/ml),
TNF-a (5 ng/ml), and IL-4 (30 ng/ml), at pH 7.3, pH 6.5 (left), or pH 7.3 in the presence of amiloride (100 mM) (right). Assessment of intracellular pH was performed
as described in Materials and Methods.
(B) Monocytes (53 105/ml) were cultured for 5 days at pH 7.3 inmedium supplementedwith 10%FCS,M-CSF (100 ng/ml), TNF-a (5 ng/ml), and IL-4 (30 ng/ml), in
the absence or presence of amiloride (100 mM). Then, the expression of CD1a, CD14, and CD16 was evaluated.
(C) Monocytes were cultured as described in (B), at pH 6.5 or pH 7.3. Then, glucose and lactate concentrations were determined by enzymatic methods.
(D) Monocytes were cultured as described in (C), in the absence or presence of DCA (dichloroacetate, 1 mM) or 2DG (2-deoxyglucose, 2 mM). Then, the
expression of CD1a, CD14, and CD16 was evaluated.
(E) Monocytes were cultured as described in (C), in the absence or presence of temsirolimus (100 nM). Then, glucose and lactate concentrations were determined
by enzymatic methods.
(legend continued on next page)






OPEN ACCESSof the total number of seeded cells that was significantly higher
for cultures performed at pH 6.than at pH 7.3 (Figure S2E). We
found that cultures performed at pH 6.5, but not at pH 7.3, re-
sulted in the differentiation of a population of DCs (Figure S2F)
that increased the expression of HLA-DR and CD86 upon LPS
stimulation (Figure S2G) and showed a high allostimulatory activ-
ity (Figure S2H). Notably, additional experiments performed in
serum-free medium revealed that differentiation of monocytes
into macrophages induced by M-CSF was redirected toward a
DC-like phenotype when cultures were performed at pH 6.5 (Fig-
ure S2I). These DCs increased the expression of HLA-DR and
CD86 upon LPS stimulation (Figure S2J) and showed a high
allostimulatory activity (Figure S2K). We also analyzed the influ-
ence of acidosis on the differentiation of mo-DCs induced by
GM-CSF and IL-4 in serum-supplemented medium (Sallusto
and Lanzavecchia, 1994). Acidosis did not promote, but rather
it partially inhibited (p < 0.05), the differentiation of mo-DCs
(Figure S3).
Low pH Induces a Fall in Intracellular pH and a
Starvation-like Response
High concentrations of protons modulate cell function by two
major mechanisms: by interacting with different families of pH
sensors expressed on the cell surface (Ishii et al., 2005; Liu
et al., 2010; Ludwig et al., 2003; Radu et al., 2005; Tong et al.,
2011) or by lowering cytosolic pH (Faucher and Naccache,
1987; Ritter et al., 1990; Simchowitz and Cragoe, 1986; Yuli
and Oplatka, 1987). We found that exposure of monocytes to
pH 6.5 resulted in a drop in cytoplasmic pH (Figure 2A, left). To
analyze if a decrease in cytosolic pH might be responsible for
the promotion of DC differentiation, we used the Na+/H+
exchanger (NHE) inhibitor amiloride. Consistent with the ability
of NHE inhibitors to induce the cytosolic accumulation of protons
(Kim et al., 1991), we found that amiloride profoundly decreased
intracellular pH (Figure 2A, right). Moreover, it significantly pro-
moted the differentiation of mo-DCs at pH 7.3 in the presence
of M-CSF, IL-4, and TNF-a (Figure 2B). Quantification of the ab-
solute number of cells in cultures performed in the presence of
amiloride confirmed that the enrichment in CD1a+CD16 cells
reflected an enhanced differentiation of monocytes into DCs
(Figure 2B, right panel). Promotion of DC differentiation induced
by amiloride was completely prevented by the AHR inhibitor
stemregenin-1 (Figure S4).
Previous studies in cell lines have shown that acidosis inhibits
glycolysis (Corbet et al., 2016; Lamonte et al., 2013). We found
that low pH as well as amiloride suppressed both glucose con-
sumption and lactate production in monocytes cultured with
M-CSF, IL-4, and TNF-a (Figure 2C). We hypothesized that inhi-
bition of glycolysis might explain, at least partially, the ability of
low pH to promote mo-DC differentiation. However, results in
Figure 2D showed that two glycolytic inhibitors, 2-deoxy-D-
glucose (2DG) and dichloroacetate (DCA), did not promote DC(F and G) Monocytes were cultured as described in (C) for 4 h at pH 7.3 in the abs
Cells incubated for 4 h at pH 6.5 were also used (F). In all cases, cells were lysed
phosphorylation status of phospho(T389)-S6K using actin as a loading control was
(G). Results are expressed as the mean ± SEM of 3–5 different donors in (A), (B, rig
7.3.differentiation. In fact, 2DG partially prevented mo-DC differenti-
ation, without affecting cell viability (data not shown). Studies
performed in cell lines have shown that the starvation response
induced by low pH involves not only the inhibition of glycolysis
but also the inhibition of the cellular nutrient sensor mTORC1
(Balgi et al., 2011; Walton et al., 2018). As expected, we found
that the mammalian target of rapamycin (mTOR) inhibitor temsir-
olimusmarkedly inhibited both glucose consumption and lactate
production (Figure 2E). Interestingly, low pH and amiloride
strongly inhibited mTORC1 activity (Figures 2F and 2G), raising
the possibility that inhibition of mTORC1 might contribute to
the ability of low pH to promote mo-DC differentiation.
mTORC1 Inhibition and Serum Starvation Promote the
Differentiation of mo-DCs
We then analyzed whether mTORC1 inhibition was able to pro-
mote the differentiation of monocytes into DCs. Figure 3A shows
that the mTORC1 inhibitor temsirolimus dramatically increased
the differentiation of mo-DCs induced by M-CSF, IL-4, and
TNF-a at pH 7.3. These mo-DCs showed a typical DC
morphology (Figure 3B) and the ability to upregulate the expres-
sion of CD86 and HLA-DR (Figure 3C) as well as the production
of IL-12 but not IL-10, IL-23, or IL-1b upon LPS stimulation (Fig-
ure 3D). Experiments performed with sorted cells indicated that
temsirolimus mo-DCs showed a high ability to induce the prolif-
eration of allogeneic T cells (Figure 3E) and the production of IL-2
and IFN-g by alloreactive lymphocytes (Figure 3F). Interestingly,
all these responses were induced at higher levels by temsiroli-
mus mo-DCs than by control mo-DCs. Contrasting with the ob-
servations made in mo-DCs differentiated at pH 7.3 and pH 6.5
(see Figure 1D), we found that the differentiation of temsirolimus
mo-DCs was not prevented by the AHR antagonist stemregenin-
1, suggesting that it bypasses the participation of AHR
(Figure S5).
Because serum activates mTOR, we hypothesized that cul-
tures performed in serum-free medium might also promote DC
differentiation. Decreasing serum concentrations from 10% to
1% promoted the differentiation of mo-DCs induced by
M-CSF, IL-4, and TNF-a (Figure 3G). We could not assay
serum-free conditions due to the high levels of cell death
observed (not shown). It has been reported that GM-CSF pro-
motes the differentiation of mo-DCs in cultures performed in
serum-free conditions (Suzuki et al., 2004). We confirmed this
previous finding (Figures 3H and 3I), andmoreover, we observed
that these DCs markedly increased CD86 expression and IL-12
production in response to LPS stimulation (Figure 3J), suggest-
ing the acquisition of an inflammatory profile.
Transcriptomic Analysis of mo-DCs
To further characterize the properties of the different mo-DC
populations arising from cultures performed at pH 7.3,
pH 6.5, or pH 7.3 plus temsirolimus, RNA-seq analysis ofence or presence of temsirolimus (100nM) (F and G) or amiloride (100 mM) (G).
and analyzed by SDS-PAGE and western blotting. Immunoblot analysis of the
performed. Representative experiments (n = 3–6) are shown in (B, left), (F), and
ht), (C), (D), (E), (F) and (G). *p < 0.05, **p < 0.001, and ***p < 0.0001; versus pH
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OPEN ACCESSsorted CD1a+CD16 cells was performed (Table S1; GEO:
GSE143170). First, we analyzed whether CD1a+CD16 cells
obtained under these experimental conditions shared a com-
mon transcriptional signature associated with DC identity (Gou-
dot et al., 2017; Segura et al., 2013). We found that
CD1a+CD16 cells from cultures performed at pH 7.3, pH
6.5, and pH 7.3 plus temsirolimus shared a high expression
of DC-associated genes, such as CD1A, CD1E, CD1B,
FCεR1A, ITGAX (CD11c), CD209 (DC-SIGN), CLEC10A,
ZBTB46, and CD83, and a low expression of macrophage-
associated genes like MERTK and CD163. A heatmap repre-
senting the gene expression data of the selected genes is
presented in Figure 4A (Table S2).
An analysis of the top 500 most variable genes (Figure 4B;
Table S3) and principal-component analysis (PCA) analysis (Fig-
ure 4C) showed that mo-DCs obtained in the presence of temsir-
olimus clustered separately from mo-DCs obtained at pH 7.3
and pH 6.5. Temsirolimus mo-DCs, on the other hand, were
shown to be enriched in the acquisition of more terminally differ-
entiated and maturation genes, such as CD1E, CD207 (Lan-
gerin), FCER1A, OCLN, CLDN1, CCR7, HLA-DQ, TNFRSF4,
and BIRC3 (Goudot et al., 2017; Jin et al., 2010; Matsunaga
et al., 2002; Villani et al., 2017; Figure 4D; Table S4). Differential
gene expression analysis between pH 6.5 and pH 7.3 mo-DCs
showed the presence of 148 upregulated and 191 downregu-
lated genes (Figure 4E; Table S5). Consistent with previous ob-
servations made in tumor cells (Corbet et al., 2016; Kondo
et al., 2017), we found that pH 6.5 promoted the expression of
genes associated with lipid metabolism and cholesterol biosyn-
thesis (Figures 4E and 4F; Table S5). Also consistent with previ-
ous studies in tumor cells and neurons (Khacho et al., 2014; Wu
et al., 2016; Xie et al., 2014), we found not only that mo-DCs
differentiated at pH 6.5 upregulated genes of the mitochondrial
respiratory chain (CI: NDUFC1, NDUFS7; CIII: UQCRB; CIV:
COX8A,COX6B1,NDUFA4) (Figures 4E and 4F; Table S5) but
also that the mitochondrial complex I inhibitor rotenone mark-
edly induced apoptosis of monocytes cultured with M-CSF,
TNF-a, and IL-4 at pH 6.5, but they exerted only minor effects
at pH 7.3 (Figure S6). This suggests a critical role for mitochon-
drial respiration in the survival of mo-DCs differentiated at low
pH values.Figure 3. mTORC1 Inhibition and Serum Starvation Promote the Differ
(A and B) Monocytes (5 3 105/ml) were cultured for 5 days at pH 7.3 in medium
(30 ng/ml), in the absence or presence of temsirolimus (100 nM). The expression
analyzed by confocal microscopy (B).
(C andD).Monocyteswere cultured as described in (A) and treated, or not, with LP
by FACS (C). Secretion of IL12 , IL10, IL23, and IL1b was determined in the supe
(E and F) Monocytes were cultured as described in (A). Then, CD16+/CD1a and
from cultures performed at pH 7.3 in the presence of temsirolimus (100nM)were so
induce the proliferation (E) and the production of IFN-g and IL-2 (F) by allogene
evaluated.
(G) Monocytes (53 105/ml) were cultured for 5 days at pH 7.3, in medium supple
and IL-4. Then, the expression of CD1a and CD14 was determined.
(H–J) Monocytes (5 3 105/ml) were cultured for 5 days in serum-free medium, in
presented in (H). A representative experiment using different concentrations of FC
medium were cultured for 24 h with or without LPS (20 ng/ml), and the expressio
periments are shown in (A, left), (B), (C, left), (E, left), (G, left), (H, left), (I), and (J, up
(D), (E, right), (F), (G, right), (H, right), and (J, low). *p < 0.05, **p < 0.001, and ***pmTOR Inhibition Turns GM-CSF into a Strong Inducer of
mo-DC Differentiation
GM-CSF promotes the differentiation of monocytes into macro-
phage-like cells in serum-supplemented medium (Lacey et al.,
2012; Sander et al., 2017). We hypothesized that the inhibition
of mTORC1 in monocytes might subvert the biological activity
of GM-CSF, promoting the differentiation of mo-DCs. Figures
5A and 5B show that mTORC1 inhibition by temsirolimus effec-
tively promoted a DC differentiation program in GM-CSF-
treated monocytes. These mo-DCs increased the expression
of CD86 and HLA-DR upon LPS stimulation in a similar fashion
as classical DCs (Figure 5C). Notably, temsirolimus mo-DCs
showed a higher production of IL-12 and a lower production
of IL-10 upon LPS stimulation than classical DCs (Figure 5D).
Moreover, temsirolimus mo-DCs displayed a strong ability to
induce the proliferation of allogeneic T lymphocytes and the
production of IFN-g by alloreactive CD4+ T cells (Figures 5E
and 5F).
DISCUSSION
Infiltration of peripheral tissues by monocytes is a common
feature in the course of inflammatory processes and also oc-
curs under steady-state conditions (Ingersoll et al., 2011). After
entering tissues, monocytes can differentiate into macro-
phages or DCs (Cheong et al., 2010; Ginhoux and Jung,
2014; Randolph et al., 1999; van Furth and Cohn, 1968), but lit-
tle is known about the environmental factors that determine this
cell fate decision. Here, we show that low pH markedly pro-
motes the differentiation of mo-DCs under different experi-
mental conditions.
A large body of evidence from studies performed in cell
lines show that acidic pH profoundly reprograms cellular
metabolism from aerobic glycolysis toward fatty acid oxida-
tion in the mitochondria (Corbet et al., 2016; Khacho et al.,
2014; Lamonte et al., 2013). In line with these observations,
we found not only that low pH inhibited glucose uptake and
lactate production in the course of DC differentiation but
also that monocytes cultured at low pH upregulated genes
of the mitochondrial respiratory chain. Also consistent with
observations made in cell lines (Balgi et al., 2011; Corbetentiation of mo-DCs
supplemented with 10% FCS, M-CSF (100 ng/ml), TNF-a (5 ng/ml), and IL-4
of CD1a, CD14, and CD16 was then evaluated (A), and cell morphology was
S during 24 h. The surface expression of CD86 andHLA-DRwas then evaluated
rnatants by ELISA(D).
CD16/CD1a+ cells from cultures performed at pH 7.3 and CD16/CD1a+ cells
rted by FACS. Cells were treatedwith LPS (20 ng/ml) for 24 h, and their ability to
ic CD4+ T lymphocytes (CD4 T cell/antigen presenting cell ratio of 4:1) were
mented with different concentrations of FCS, in the presence of M-CSF, TNFa,
the presence of GM-CSF (50 ng/ml). FACS analysis of the recovered cells is
S is shown in (I). Then, cells recovered from cultures performed in serum-free
n of CD86 and the production of IL-12 were analyzed (J). Representative ex-
). Results are expressed as the mean ± SEM of 3–6 different donors in (A, right),
< 0.0001; versus controls.
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Figure 4. Transcriptomic Analysis of mo-DCs
(A–F) Monocytes were cultured in the presence of M-CSF (100 ng/ml), TNFa (5 ng/ml), and IL-4 (30 ng/ml) for 5 days at pH 7.3, pH 6.5, or pH 7.3 in the presence of
temsirolimus (100 nM). Then, CD1a+CD16 cells were sorted by FACS, and RNA was extracted for RNA-seq analysis (n = 6).
(A) Heatmap presenting the log2 normalized expression data of selected genes corresponding either to macrophage-associated or DC-associated signatures.
(B) Top 500 highly variable genes and K-means clustering.
(C) PCA analysis of the top 500 highly variable genes.
(D) Venn diagram and volcano plot of differentially expressed genes obtained using DESeq2 (false discovery rate [FDR] > 0.05, fold change [FC] > 1) (pH 7.3 +
temsirolimus versus pH 7.3).
(E) Venn diagrams and volcano plots of differentially expressed genes obtained using DESeq2 (FDR > 0.05, FC > 1) (pH 6.5 versus pH 7.3).
(F) Schematic representation of up- and down-modulated groups of genes after pathway analysis (pH 6.5 versus pH 7.3).
Report
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OPEN ACCESSet al., 2016; Lamonte et al., 2013; Walton et al., 2018), we
found that low pH markedly inhibited the activity of mTORC1,
a cellular nutrient sensor that plays an essential role in cell
growth and survival (Kim and Guan, 2019; Saxton and Saba-
tini, 2017). Interestingly, the NHE inhibitor amiloride repro-
duced all the effects, suggesting that a drop in cytoplasmic8 Cell Reports 31, 107613, May 5, 2020pH might explain, at least partially, the ability of extracellular
pH to promote mo-DC differentiation.
Here, we also reported that the mTORC1 inhibitor temsiroli-
mus markedly promotes mo-DC differentiation. We found a
similar response in different cytokine contexts, i.e., in the pres-




Figure 5. mTOR Inhibition Turns GM-CSF into a Strong Inducer of mo-DC Differentiation
(A and B) Monocytes (13 106/ml) were cultured for 5 days at pH 7.3 in medium supplemented with 10% FCS and GM-CSF (50 ng/ml), in the absence or presence
of temsirolimus (100 nM). Then, the expression of CD1a, CD1c, and CD14 was determined (A), and cell morphology was analyzed by confocal microscopy (B).
Classical DCs, obtained from monocytes cultured with GM-CSF and IL-4 were used as controls.
(C and D)Monocytes were cultured as described in (A) and treated, or not, with LPS during 24 h. Then, the phenotype (C) and the production of different cytokines
were evaluated (D).
(E and F) Monocytes were cultured as described in (A) and treated, or not, with LPS during 24 h. Their ability to induce the proliferation (E) and the production of
IFN-g by allogeneic CD4+ T lymphocytes (CD4 T cell/antigen presenting cell ratio of 4:1) (F) was then evaluated. Representative experiments are shown in (A, left),
(B), (C, left), and (E, left). Results are expressed as the mean ± SEM of 3–6 different donors in (A, right), (C, right), (D), (E, right), and (F). *p < 0.05, **p < 0.001, and
***p < 0.0001; versus controls.
Report
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OPEN ACCESSGM-CSF. In contrast, and in agreement with previous results
(Haidinger et al., 2010), we observed (data not shown) that inhi-
bition of mTORC1 resulted in diminished cell viability in mono-cytes cultured with GM-CSF and IL-4. Together, these observa-
tions indicate that the role of mTOR in the differentiation of mo-
DCs is strongly dependent on the cytokine environment.Cell Reports 31, 107613, May 5, 2020 9
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OPEN ACCESSEarly studies identified mTORC1 inhibitors as immunosup-
pressive agents and were, thus, used to prevent allorejection in
transplanted patients (Saunders et al., 2001; Thomson et al.,
2009). More recent studies, however, suggested a more com-
plex picture. Rapamycin-mediated inhibition of mTOR has
been shown to increase CD8+ T cell memory (Araki et al.,
2009; Diken et al., 2013; Ferrer et al., 2010; Li et al., 2012; Rao
et al., 2010). Interestingly, Haidinger et al. (2010) reported diver-
gent roles for mTOR on blood DCs and DCs derived frommono-
cytes cultured with IL-4 and GM-CSF. Studies performed in mu-
rine models have shown that mTORC1 plays an important role in
the development of different populations of DCs, such as the
Flt3L-dependent CD8+ DC subset (Sathaliyawala et al., 2010)
and Langerhans cells (Kellersch and Brocker, 2013; Sukhbaatar
et al., 2016). Moreover, a number of studies showed that mTOR
inhibition promotes an inflammatory signature by already differ-
entiated DCs (Amiel et al., 2012; Jagannath and Bakhru, 2012;
Weichhart et al., 2008; Mineharu et al., 2014). Our present results
suggest that mTOR inhibition might contribute to inflammatory
reactions not only by promoting the acquisition of an inflamma-
tory signature by already differentiated DCs but also by inducing
the differentiation of tissue-infiltrating monocytes into mo-DCs.
Despite that low pH markedly inhibited mTORC1 activity, our
observations show a number of differences between the actions
induced by low pH and the mTORC1 inhibitor temsirolimus.
Transcriptomic analysis of DCs showed major differences.
Moreover, the AHR antagonist stemregenin-1 completely
prevented the differentiation of mo-DCs in the context of
M-CSF/IL-4/TNF-a stimulation at pH 6.5 without affecting the
differentiation of mo-DCs promoted by temsirolimus. Finally,
temsirolimus strongly induced the differentiation of mo-DCs in
the context of GM-CSF stimulation, whereas low pH did not
exert any significant effect. Further studies are required to define
the contribution of mTORC1 inhibition to the promoting effect of
low pH on mo-DC differentiation.
The mechanisms through which mTORC1 inhibition promotes
mo-DC differentiation remain to be elucidated. Different down-
stream effectors of the starvation response might be causally
implicated. mTORC1 acts as a link between cell nutritional status
and protein acetylation state (Wan et al., 2017; Wellen et al.,
2009). Serum deprivation (Wellen et al., 2009) and mTORC1 inhi-
bition (Wan et al., 2017) have been shown to promote major
changes in mitochondrial and cytosolic protein acetylation pat-
terns while inducing global histone deacetylation. Classical his-
tone deacetylases (HDACs) and Sirtuins, a type III HDAC, directly
modulate gene expression by deacetylating histones and regu-
lating the acetylation pattern of a variety of non-histone proteins,
thus impinging on several cellular processes (Yang and Seto,
2007; Yao and Yang, 2011). We hypothesize that the induction
of a starvation response induced by either serum deprivation
or mTORC1 inhibition might drive the differentiation of mo-DCs
by promoting changes in the acetylation pattern of histones
and non-histone proteins. Supporting this hypothesis, it has
been reported that the differentiation of mo-DCs is dependent
on the activity of HDACs (Chauvistré et al., 2014; Nencioni
et al., 2007). Moreover, our transcriptomic analysis of temsiroli-
mus mo-DCs revealed the upregulation of two HDACs, namely,
HDAC-1 and the type III HDAC SIRT1, which have previously10 Cell Reports 31, 107613, May 5, 2020shown to play an important role in the modulation of DC function
(Chauvistré et al., 2014; Owczarczyk et al., 2015; Reddy et al.,
2008). Notably, previous observations have also shown not
only that acidosis leads to a NAD+-dependent increase in the ac-
tivity of the histone deacetylases SIRT1 and SIRT6 but also that
tumor acidosis accounts for a net increase in tumor sensitivity to
SIRT1 inhibitors (Corbet et al., 2016; McBrian et al., 2013). We
hypothesize that modulation of HDAC expression and activity
might represent a final common pathway through which acidosis
and mTORC1 inhibition promoted the differentiation of mono-
cytes into DCs.
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Chauvistré, H., K€ustermann, C., Rehage, N., Klisch, T., Mitzka, S., Felker, P.,
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Deposited Data
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Materials Availability
This study did not generate new unique reagents.
Data and Code Availability
The accession number for the RNA-seq data reported in this paper is GEO: GSE143170.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human blood samples
Buffy coats from healthy donors (both male and female donors) were obtained from Sanatorio Mendez (Buenos Aires, Argentina) and
heparinized human blood samples were obtained from Hospital de Clı́nicas ‘‘José de San Martı́n,’’ Facultad de Medicina,Cell Reports 31, 107613, May 5, 2020 e2
Report
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OPEN ACCESSUniversidad de Buenos Aires. All the human blood samples used in this study would have been obtained even if this study was not
carried out, and they were supplied without any personal identifiable information.
METHOD DETAILS
Cell Isolation
PBMCswere isolated by centrifugation on Ficoll-Paque (GEHealthcare, Argentina). Monocytes were isolated fromPBMCs by Percoll
gradient centrifugation as described (Menck et al., 2014) or by positive selection using anti-CD14-coated magnetic beads according
to themanufacturer’s instructions (Miltenyi) (% purity 80-97). CD4+ T cells were isolated from heparinized blood samples by negative
selection using RosetteSep immunodensity procedure (Cell Signaling Technologies) (% purity > 95).
Cell cultures
All the experiments were performed using RPMI-1640 medium supplemented with 50 U/ml penicillin, 50 mg/ml streptomycin and
different percentages of fetal calf serum (FCS, GIBCO Invitrogen). Monocytes (5x105cells/ml) were cultured with or without the addi-
tion of M-CSF, TNFa, GM-CSF and/or IL-4 (Miltenyi) for different periods of time. L-Phytohemagglutinin (L-PHA, 1mg/ml, SIGMA/
Merk) was used to stimulate PBMCs. Cultures performed in serum-free medium were performed in culture medium supplemented,
or not, with 0.1% bovine serum albumin (BSA) (DSF Labs, Argentina). pH in the cultures was adjusted using isotonic HCl, as previ-
ously described (Jancic et al., 2012). pH values were determined on each day of the culture, in experiments performed in duplicate.
Cultures performed at pH 7.3 remained in the pH range 7.4 to 7.2 along the culture period. Those performed at pH 6.5 remained at pH
6.5-6.8 along the culture.
Flow cytometry & cell sorting
The analysis was performed by using a BD FACSCanto cytometer and BD FACSDiva software. APC anti-CD1a (# 559775), FITC anti-
CD1a (#555806), BV421 anti-CD14 (#563743), FITC anti-CD14 (#555397), PE anti-CD14 (555398), PE anti-CD16 (#347617), FITC
anti-CD64 (#555527), APC anti-CD209 (#551545), PE anti-CD1c (#564900), PE anti-CD86 (# 555658), FITC anti-CD80 (#560926),
FITC anti-HLA-DR (#555811), APCCy7 anti-HLA-DR (#335796), APCCy7 anti-CD11b (#557754), APC anti-CD11c (#559877) were
obtained from BD Biosciences. Sorting of CD1a+CD16- cells was performed using a BD FACSCanto cytometer.
Fluorescence and confocal microscopy
Cells were washed with PBS and resuspended in fresh RPMI medium followed by 30 minutes adhesion on poly-L-Lysine coated
glass coverslips. Attached cells were washed with PBS and fixed with 4% PFA solution at 4 for 15 min. Afterward, coverslips
were treated for 10 minutes with glycin 0.1M in PBS solution to quench aldehyde group autofluorescence and blocked with 1%
BSA solution in PBS. Coverslips were then incubated for 1h at room temperature with mouse IgG anti-human-CD1a (#555805) in
PBS 1% BSA (1:50 dilution) washed and incubated for 1h at room temperature with Alexa488 anti-mouse IgG (1:500) (Jackson
Immuno Research) and Alexa594-phalloidin (Thermo Fisher) (1:200). The coverslips mounted with DAPI-Fluoromount-G (Southern-
Biotech) were examined under a confocal microscope (ZEISS LSM 900) using a Plan Apochromat 633 1.42 NA oil immersion objec-
tive or under an Eclipse Ti-S fluorescence microscope (Nikon) using a Plan Apochromat 100 3 1.42 NA oil immersion objective.
Measurement of cytokines by ELISA
Supernatants frommonocyte-derived cells (5x105/ml), stimulated or not with LPS for 18h, were harvested and analyzed for the pres-
ence of IL-12(p70), IL-10, IL-1b, IL-23, TNFɑ, and IL-6. Supernatants collected from theMLRs at day 6 of culture were analyzed for the
presence of IFNɣ, IL-5, and IL-17. ELISA was performed with BD OptEIA sets according to the manufacturer recommendations or
using CBA Human Th1/Th2 Cytokine Kit II (BD).
Mixed Lymphocyte Reaction
Isolated CD4+ T cells (13 107 cells/ml) were labeled with 5 mMCFSE (Molecular Probes, Invitrogen) in PBS for 5 min at 37 C. Cells
were washed and plated (2x105/200 ml) in 96well plates. Allogeneic monocyte-derived cells were counted and added to lymphocytes
using an APC/CD4+T cell ratio of 1:10, 1:4 or 1:2. After 6 days of culture, cells were harvested and CFSE dilution was assessed by
flow cytometry. Quantification of CD4+ T cell proliferation was determined by determining the fraction of T cells that diluted CFSE
dye.
Measurement of intracellular pH
It was performed using BCECF-AM as previously described (Chow et al., 1996). Briefly, monocytes (1x106/ml) were loaded in PBS
with 1 mg/ml BCECF-AM during 15 min at 37 C, washed in PBS, and resuspended in culture medium (5 3 105/ml), adjusted to
different pH values, in the absence or presence of the Na+/H+ antiporter inhibitor amiloride (100nM). Then, cells were cultured for
12 h in the presence of M-CSF + TNFɑ + IL-4 and the values of intracellular pH for each condition were determined. The analysis
was performed by flow cytometry, with excitation at 488 nm and emission analysis at FL1 and FL3. The intracellular pH wase3 Cell Reports 31, 107613, May 5, 2020
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OPEN ACCESScalculated from the ratio of emission intensities at the two wavelengths, standardizing by comparison with the fluorescence intensity
ratios of cells whose pHi values were fixed by incubation with nigericin (10 mM) in high-potassium buffers.
Analysis of glucose and lactate concentrations
Monocytes were cultured under different conditions at a concentration of 5x105 cells/ml. After 3 days, glucose and lactate
concentrations in culture supernatants were assessed using conventional enzymatic methods according to the manufacturer’s rec-
ommendations: Enzymatic Glycemia (#1400060) and Lactate (#1999795) determination kits from Wiener Lab, Argentina.
Cell lysates and immunoblots
Cells were washed in cold PBS and pellets were lysed in 4 x Laemmli sample buffer (Bio-Rad) with the addition of phosphatase in-
hibitor (Merk) and protease inhibitor cocktails (Roche). Equal amounts of lysates were separated on 12% SDS-PAGE, blotted on
Polyvinylidene Fluoride Transfer Membrane (Thermo Fisher Scientific). Blots were revealed using SuperSignal West Pico Chemilu-
minescent Substrate (Thermo Fisher Scientific). The intensity of the bands was quantified using the software ImageJ (National Insti-
tutes of Health) (Schneider et al., 2012). Anti Phospho-p70 S6 Kinase (Thr389) antibody (#9205, Cell Signaling) and Anti b-actin
(#MA5-15739, Thermo Fisher Scientific- Invitrogen) were used as primary antibodies. HRP conjugated secondary antibodies were
purchased from Jackson ImmunoResearch.
RNA-seq library preparation
RNA from sorted cells (250.000-500.000 CD1a+CD16- cells) was extracted by using RNeasy Mini Kit (QIAGEN), including on-column
DNase digestion as described by themanufacturer’s protocol. The integrity of the RNAwas confirmed in BioAnalyzer using RNA 6000
Pico kit (Agilent Technologies). cDNA was generated with SMART-Seq v4 Ultra Low Imput RNA Kit for Sequencing (Takara) following
manufacturer instructions. In order to amplify the RNA, 14 cycles were used. The quantity and quality of cDNA were assessed with
Qubit dsDNA high sensitivity (Thermofisher) and an Agilent Bioanalyzer using nanochip (Agilent Technologies), respectively. Unique
dual indexed libraries were obtained using Kapa HyperPlus Kit (Roche) based on cDNA as starting materials. Sequencing of a pool of
multiplexes libraries was performed on a NovaSeq system (Illumina) using a S1 flow cell in a paired-end 100 nts mode (PE100) allow-
ing to get anminimum average depth of 20million reads. Libraries, sequencing and quality control of the sequencing were performed
by the ICGex NGS facility at Institut Curie.
RNA-seq analysis
Genome assembly was based on the Genome Reference Consortium (hg38). Quality of RNA-seq data was assessed using FastQC
(Andrews, 2010). Reads were pseudo-aligned to the transcriptome using Salmon (Patro et al., 2017) and transcript expression values
were summarized using tximport (Soneson et al., 2015). Identification of the top 500 highly variable was performed using iDEP.90
software (http://bioinformatics.sdstate.edu/idep/) (Ge et al., 2018). Genes with < 1 CPM in at least 3 libraries were filtered out,
and counts data was transformed for clustering and PCA using EdgeR (log2(CPM+c)) (pseudocount c = 4). Unsupervised K means
clustering of the 500 highly variable genes was performed considering 3 clusters and mean centered gene normalization. Differential
gene expression analysis was performed using iDEP.90 software (Ge et al., 2018) and the Bioconductor packageDESeq2 (Love et al.,
2014). Statistically significant differentially expressed genes were considered when < 0.05 FDR and FC > 1. The list of upregulated
and downregulated differentially expressed genes was used for pathway analysis using ShinyGO v0.61 (Ge et al., 2019) (http://
bioinformatics.sdstate.edu/go/) and the databases: Reactome, KEGG and GO Biological process. Heatmaps were plotted using
Morpheus (https://software.broadinstitute.org/morpheus). Volcano plots were performed using R Studio Version 1.2.5001 and DE-
Browser shinny application (Kucukural et al., 2019).
Chemicals
Amiloride hydrochloride hydrate, temsirolimus, 4,7-dimethyl-1,10-phenanthroline, 2-deoxyglucose (2DG), dichloroacetate (DCA),
dexamethasone, and PGE2 were purchased from Sigma-Aldrich-Merck. Stemregenin 1 and 6-formylindolo[3,2-b]carbazole (FICZ)
were purchased from Cayman Chemical Company.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
Data were analyzed using Wilcoxon nonparametric paired test in which P values of < 0.05 were considered statistically significant.
Analysis was performed using GraphPad Prism V5. ‘‘n’’ corresponds to the number of individual donors analyzed.Cell Reports 31, 107613, May 5, 2020 e4
